24 results for “opinion”
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
Dave Barton, co-founder and creative director at cannabis content agency, thermidor<, explores the challenges brands face in marketing medical cannabis and wonders whether any of them are actually doing it […]
Head grower at Dalgety, Brady Green, explores the difference between prescribed cannabis and its illegal counterpart.
Prince Harry comments are not only relatable to many, but are backed up by a growing body of research.
Patrick Moore was supplying cannabis oil to patients with cancer and other chronic illnesses.
Casper James* says the plant has helped him recover from alcohol addiction and embrace his creativity.
A cannabis patient writes about the personal impact of prohibition.
A holistic approach to prescribing has seen “life-changing” results in Jersey, writes Dr Mark Wilbourn.
Dr Mark Smith is a UK-trained GP who has prescribed medical cannabis to more than 200 patients in Australia.
France’s incoming generalised medical cannabis framework has edged closer to clearing its last remaining hurdle.
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
YouGov has published a representative survey examining the British public’s attitudes towards cannabis.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
Spain’s Council of Ministers has approved a Royal Decree regulating the medicinal use of cannabis preparations in hospital settings.
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing […]
A class action alleges that Aurora ‘negligently failed’ to warn consumers of the risk of developing CHS posed by the regular use of its products.
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner.
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university. Just days after Switzerland announced […]
Cannabis clinics can play a crucial role in changing this landscape by setting high professional standards and ensuring patients receive the same level of care as with any other medical treatment.
The FDA has given MAPS the green light to carry out a study in 320 veterans suffering from moderate to severe PTSD.
